The regulation of muscle protein turnover in diabetes.

[1]  T. Hostetter,et al.  Effects of oral sodium bicarbonate in patients with CKD. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[2]  A. Chawla,et al.  Pleiotropic Actions of Insulin Resistance and Inflammation in Metabolic Homeostasis , 2013, Science.

[3]  R. Gougeon,et al.  Muscle protein anabolism in type 2 diabetes , 2013, Current opinion in clinical nutrition and metabolic care.

[4]  S. Anker,et al.  Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. , 2012, International journal of cardiology.

[5]  S. Walrand,et al.  Impaired protein metabolism: interlinks between obesity, insulin resistance and inflammation , 2012, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[6]  Maria A. Fiatarone Singh,et al.  The Anabolic Androgenic Steroid Oxandrolone in the Treatment of Wasting and Catabolic Disorders , 2012, Drugs.

[7]  S. Ghosh,et al.  NF-κB, inflammation, and metabolic disease. , 2011, Cell metabolism.

[8]  M. Binns,et al.  Identification of the myostatin locus (MSTN) as having a major effect on optimum racing distance in the Thoroughbred horse in the USA. , 2010, Animal genetics.

[9]  D. Lacey,et al.  Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival , 2010, Cell.

[10]  G. Biolo,et al.  Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". , 2010, Clinical nutrition.

[11]  K. Nair,et al.  Protein and energy metabolism in type 1 diabetes. , 2010, Clinical nutrition.

[12]  S. Welle,et al.  Genetic Deletion of Myostatin From the Heart Prevents Skeletal Muscle Atrophy in Heart Failure , 2010, Circulation.

[13]  L. Kuller,et al.  Excessive Loss of Skeletal Muscle Mass in Older Adults With Type 2 Diabetes , 2009, Diabetes Care.

[14]  W. Mitch,et al.  Ubiquitin, proteasomes and proteolytic mechanisms activated by kidney disease. , 2008, Biochimica et biophysica acta.

[15]  G. Bray,et al.  Altered body composition in type 2 diabetes mellitus , 2008, International Journal of Obesity.

[16]  R. Gougeon,et al.  Insulin Resistance of Protein Metabolism in Type 2 Diabetes , 2008, Diabetes.

[17]  W. Mitch,et al.  Development of a diagnostic method for detecting increased muscle protein degradation in patients with catabolic conditions. , 2006, Journal of the American Society of Nephrology : JASN.

[18]  W. Mitch,et al.  Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. , 2006, Endocrinology.

[19]  B. Draznin Molecular Mechanisms of Insulin Resistance: Serine Phosphorylation of Insulin Receptor Substrate-1 and Increased Expression of p85α , 2006, Diabetes.

[20]  E. Carson,et al.  The effect of metabolic control on leucine metabolism in Type 1 (insulin-dependent) diabetic patients , 1986, Diabetologia.

[21]  T. Ikizler,et al.  Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. , 2005, Kidney international.

[22]  N. Rosenthal,et al.  Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. , 2005, The Journal of clinical investigation.

[23]  W. Frontera,et al.  IKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice , 2004, Cell.

[24]  J. Williamson,et al.  Antihypertensive Medications and Differences in Muscle Mass in Older Persons: The Health, Aging and Body Composition Study , 2004, Journal of the American Geriatrics Society.

[25]  B. Dahlmann,et al.  Alterations of proteasome activities in skeletal muscle tissue of diabetic rats , 1999, Molecular Biology Reports.

[26]  Seumas McCroskery,et al.  Myostatin negatively regulates satellite cell activation and self-renewal , 2003, The Journal of cell biology.

[27]  Ralph A. DeFronzo,et al.  Metabolic and molecular basis of insulin resistance , 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[28]  E. Eldrup,et al.  Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes , 2003, Mechanisms of Ageing and Development.

[29]  Abdissa Negassa,et al.  Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study , 2003, The Lancet.

[30]  Theodore J Thompson,et al.  Excess physical limitations among adults with diabetes in the U.S. population, 1997-1999. , 2003, Diabetes care.

[31]  K. Petersen,et al.  Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. , 2002, The Journal of clinical investigation.

[32]  S. Madsbad,et al.  Body composition in adults with Type 1 diabetes at onset and during the first year of insulin therapy , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[33]  W. Mitch,et al.  Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle. , 2002, Kidney international.

[34]  Michael Karin,et al.  Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ , 2001, Science.

[35]  P. Choong,et al.  Myostatin, insulin‐like growth factor‐1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy , 2001, Muscle & nerve.

[36]  F. Booth,et al.  IGF‐I restores satellite cell proliferative potential in immobilized old skeletal muscle , 2000, Journal of applied physiology.

[37]  S. Yusuf,et al.  Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. , 2000, European heart journal.

[38]  C. Castaneda,et al.  Protein nutritional status and function are associated with type 2 diabetes in Hispanic elders. , 2000, The American journal of clinical nutrition.

[39]  L. Mandarino,et al.  Fuel selection in human skeletal muscle in insulin resistance: a reexamination. , 2000, Diabetes.

[40]  M. Lean,et al.  Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes. , 1999, Diabetes care.

[41]  Se-Jin Lee,et al.  Double muscling in cattle due to mutations in the myostatin gene. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[42]  R E Grindeland,et al.  Apoptosis: a mechanism contributing to remodeling of skeletal muscle in response to hindlimb unweighting. , 1997, The American journal of physiology.

[43]  A. Goldberg,et al.  Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. , 1996, The New England journal of medicine.

[44]  W. Mitch,et al.  The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. , 1996, The Journal of clinical investigation.

[45]  E. Barrett,et al.  Insulin and insulin-like growth factor-I enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms. , 1995, The Journal of clinical investigation.

[46]  G. Biolo,et al.  Physiologic hyperinsulinemia stimulates protein synthesis and enhances transport of selected amino acids in human skeletal muscle. , 1995, The Journal of clinical investigation.

[47]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[48]  P. Björntorp Metabolic Implications of Body Fat Distribution , 1991, Diabetes Care.

[49]  H. Keen,et al.  RESTRICTION OF DIETARY PROTEIN AND PROGRESSION OF RENAL FAILURE IN DIABETIC NEPHROPATHY , 1989, The Lancet.

[50]  P. Roach,et al.  Insulin resistance in denervated skeletal muscle. Inability of insulin to stimulate dephosphorylation of glycogen synthase in denervated rat epitrochlearis muscles. , 1988, The Journal of biological chemistry.

[51]  G. Dohm,et al.  Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. , 1987, The Journal of clinical investigation.

[52]  P. Tessari,et al.  Inverse relationship of leucine flux and oxidation to free fatty acid availability in vivo. , 1986, The Journal of clinical investigation.

[53]  C. Burant,et al.  Diabetes-induced functional and structural changes in insulin receptors from rat skeletal muscle. , 1986, The Journal of clinical investigation.

[54]  J. Knochel,et al.  Correction of uremic cellular injury with a protein-restricted amino acid-supplemented diet. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[55]  R. Sherwin,et al.  Amino acid and protein metabolism in diabetes mellitus. , 1977, Archives of internal medicine.

[56]  F. Cunha The Ebers papyrus. , 1949, American journal of surgery.

[57]  Ralph Hermon Major,et al.  Classic Descriptions of Disease with Biographical Sketches of the Authors , 1939, Nature.

[58]  R. Loeb,et al.  ON DIABETIC ACIDOSIS: A Detailed Study of Electrolyte Balances Following the Withdrawal and Reestablishment of Insulin Therapy. , 1933, The Journal of clinical investigation.